Efficacy of CFTR modulator agent (ivacaftor, lumacaftor/ ivacaftor and tezacaftor/ivacaftor) in cystic fibrosis patients: A single center observational study
Latest Information Update: 23 Oct 2020
At a glance
- Drugs Ivacaftor (Primary) ; Ivacaftor/lumacaftor (Primary) ; Ivacaftor/tezacaftor (Primary)
- Indications Cystic fibrosis
- Focus Adverse reactions; Therapeutic Use
- 23 Oct 2020 New trial record
- 23 Sep 2020 Results presented at the 2020 American College of Clinical Pharmacology Annual Meeting